Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cáñamo y Fibras Naturales (Cafina) is a Spanish licensed cannabis producer authorized by the Spanish Agency of Medicines and Medical Devices (AEMPS) to cultivate Cannabis sativa for medicinal and research purposes, including production of flowers, leaves and extraction of cannabinoids; it has focused on research-related medical cannabis cultivation and hemp-derived products and was acquired in 2019 by Canopy Growth to expand its European medical cannabis production footprint.[1][2]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cáñamo y Fibras Naturales.